T 2749/18 (GLP-1 agonists/GSK) of 11.06.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T274918.20240611
- Date of decision
- 11 June 2024
- Case number
- T 2749/18
- Petition for review of
- -
- Application number
- 06839697.7
- IPC class
- C07K 1/00A61K 38/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods for administering hypoglycemic agents
- Applicant name
- GlaxoSmithKline LLC
- Opponent name
- Novo Nordisk A/S
Sanofi
Generics [UK] Limited
Eli Lilly and Company - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step (no), partial problems
- Catchword
- -
- Cited cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.